AGENTIX CORP.

AGTX ·Healthcare, Drug Manufacturers - General, United States
Financial Statements Income Statement
Annual Quarterly

Income Statement

Line Item Dec 2022 Sep 2022 Dec 2021 Sep 2021 Aug 2021 May 2021 Feb 2021 Nov 2020
Revenue $0 $0 $0 $1.2K $1.2K $0 $0 $0
Cost of Revenue $0 $0 $0 $561
Gross Profit $0 $0 $0 $679
Gross Margin 54.8%
Operating Expenses
Research & Development $192.0K $284.5K $65.4K $91.5K $57.5K $178.3K $15.5K
SG&A Expense $21.8K $71.8K $15.3K $15.3K $17.6K $16.8K $16.7K
Operating Income $-353.6K $-424.3K $-187.0K $-220.2K $-173.2K $-707.1K $-216.7K
Operating Margin -17,761.9%
Interest Expense $0 $0 $0
Pretax Income $-353.6K $-424.3K $-187.0K $-220.2K $-173.2K $-707.0K
Income Tax Expense $0 $0 $0 $0 $0 $0 $0
Net Income $-353.6K $-424.3K $-187.0K $-220.2K $-243.4K $-173.2K $-707.1K $-216.7K
Net Margin -17,761.9% -19,631.1%
EPS (Basic) $-0.01 $0.00 $-0.02 $-0.01
EPS (Diluted) $-0.01 $0.00 $-0.02 $-0.01
Shares Outstanding (Basic) 39.1M 39.1M 34.9M 34.9M 34.9M 34.5M
Shares Outstanding (Diluted) 39.1M 39.1M 34.9M 34.9M 34.9M 34.5M
Dividends Per Share
← Newer Page 1 of 2 Older →